What factors guide the decision whether to continue breastfeeding or ticagrelor treatment?

The decision whether to discontinue breastfeeding or discontinue/abstain from ticagrelor treatment must weigh breastfeeding’s benefit for the child against treatment’s benefit for the woman, recognising that animal data show ticagrelor and active metabolites enter milk and a risk to newborns/infants cannot be excluded.